Brief: Phio Pharmaceuticals Presents Positive New Data On Systemic Immune Response After Local PH-762 Therapy
12/11/2021 12:37
Nov 12 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS PRESENTS POSITIVE NEW DATA ON
SYSTEMIC
IMMUNE RESPONSE AFTER LOCAL PH-762 THERAPY AT THE SITC 36TH
ANNUAL MEETING
Source text for Eikon: ID:nPnb7y3Cza
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing